The Aging Male · 2008 · 12 citations · 8 references
MedicinePharmacologyPharmacotherapyAndrologyClinical PharmacologyPharmacodynamicsEfficacy EvaluationErectile DysfunctionSexual DysfunctionVitamin E DeficiencyVitamin SupplementationErectile Dysfunction CareErectile Function RestorationInformed ConsentPde5 InhibitorsPhosphodiesterase SignalingPhosphodiesterase Type 5 Inhibitor TherapyPhosphodiesterase Type 5 InhibitorsSalvage Combination Therapy
We report our initial experience with salvage therapy for low responders to PDE-5 inhibitors by adding vitamin E. Of 89 patients with ED who visited our clinic between January 2004 to August 2006, 9 were unable to obtain a full response to a PDE-5 inhibitor and included in the present study. After providing informed consent, each was given 300 mg per day of alpha-tocophenol at least 1 month and completed IIEF-5 questionnaires to assess its efficacy while also taking a PDE-5 inhibitor. With alpha-tocophenol administration, the average IIEF-5 score increased from 13.8 +/- 3.2 to 17.1 +/- 3.6. Four of seven patients who completed the questionnaire each time showed improved IIEF-5 scores, with a maximum elevation of 9 points. Further, eight of the nine patients experienced favourable subjective changes, the majority being increased penile rigidity. The present clinical trial results are, to our knowledge, the first known to show the effects of vitamin E for enhancing the efficacy of a PDE-5 inhibitor.
8
Nitric Oxide: A Physiologic Mediator of Penile Erection
Arthur L. Burnett, Charles J. Lowenstein, David S. Bredt et al. · Science · 1992 · 1.2K citations
Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes
Marc Rendell, Jacob Rajfer, Pierre Wicker et al. · JAMA · 1999 · 619 citations
Medicine, Endocrinology, Urology +14